Search

Search Results for "REGENXBIO"

The Art of Drug Choice: International Panel in Wet AMD: The Pipeline

ASRS 2021: The Pipeline for Wet AMD and GA

The Art of Drug Choice: Wet AMD Pipeline

Thumbnail for pjrit

RGX-314 for Wet AMD

Robert Avery MD, PhD

Thumbnail for hjkas

RGX-314: Phase 1/2a Data

Arshad Khanani, MD

An Update on Suprachoroidal RGX-314 thumbnail

An Update on Suprachoroidal RGX-314

David S. Boyer, MD

Gene Therapy for Wet AMD: Pharmacodynamic Changes thumbnail

Gene Therapy for Wet AMD: Pharmacodynamic Changes

Ramanath Bhandari, MD

Thumbnail for mddor

How Gene Therapy Could Change How We Treat Wet AMD

Jeffrey Heier, MD

Fellow-Eye Dosing of ABBV-RGX-314 Gene Therapy thumbnail

Fellow-Eye Dosing of ABBV-RGX-314 Gene Therapy

Arshad M. Khanani, MD, MA, FASRS

Next-Gen Therapies for AMD and DME thumbnail

Next-Gen Therapies for AMD and DME

Nicole Eter, MD

Pharmacodynamics of ABBV-RGX-314 thumbnail

Pharmacodynamics of ABBV-RGX-314

Robert L. Avery, MD

Thumbnail for rdlom

Three Exciting New Drugs

Pravin U. Dugel, MD

New Retina Radio AAO Late-Breakers: ALTITUDE and DIAMOND

Mark Barakat, MD; and And Hani Salehi-Had, MD

The Art of Drug Choice: International Panel in Wet AMD: The Pipeline

Arshad M. Khanani, MD; Justus G. Garweg, MD; Seenu M. Hariprasad, MD; Peter Kertes, MD, FRCSC

ASRS 2021 Coverage: The Pipeline for Wet AMD and GA

Mark Barakat, MD; and Nancy Holekamp, MD

The Art of Drug Choice: Wet AMD Pipeline

Arshad M. Khanani, MD, MA; Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA

View More